Physician profile
Mohammad Goodarzi
NPI 1659459501
$3,278.43
in general payments reported to CMS, 2019-2025
9 companies · $543 in 2025
The $543 reported for 2025 was more than what 91% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.10 · 2020: $606 · 2021: $424 · 2022: $224 · 2023: $1,393 · 2024: $67.57 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $1,095 · Food and Beverage: $458 · Education: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $1,094.69 |
| Food and Beverage | $458.29 |
| Education | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $1,263.92 | 2022-2023 | Opalescence |
| Align Technology, INC. | $1,090.33 | 2019-2025 | Invisalign, Itero Element 5d Plus |
| Zimmer Biomet Holdings, INC. | $650.00 | 2020-2021 | |
| Purelife, LLC | $100.00 | 2020 | |
| Zimvie INC. | $75.00 | 2023 | |
| Kerr Corporation | $30.75 | 2023 | Harmonize |
| Nobel Biocare USA | $30.74 | 2023 | Nobelactive |
| Dentsply Sirona INC | $26.08 | 2024 | Protaper Gold Conform Fit |
| Gc America INC. | $11.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Goodarzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.